Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ambler

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Neurology|March 1, 1980
Adult celiac disease presenting as cerebellar syndromeP F Finelli, W J McEntee, M Ambler, et al.
Neurology|December 1, 1984
Cerebro-ocular dysgenesis (Walker-Warburg syndrome): neuropathologic and etiologic analysisR S Williams, C N Swisher, M Jennings, et al.
Archives of Neurology|March 1, 1978
Dominant spinopontine atrophy. Report of two additional members of family WS Pogacar, M Ambler, W J Conklin, et al.
Current Pharmaceutical Design|October 2, 2014
Strategies for skeletal muscle targeting in drug discoveryDavid C Ebner, Peter Bialek, Ayman F El-Kattan, et al.
Current Topics in Medicinal Chemistry|April 13, 2013
Intestinal targeting of drugs: rational design approaches and challengesKevin J Filipski, Manthena V Varma, Ayman F El-Kattan, et al.
Molecular Pharmaceutics|October 28, 2017
Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623Claire L McEvoy, Natalie L Trevaskis, Orlagh M Feeney, et al.
Current Drug Metabolism|December 30, 2010
Targeting intestinal transporters for optimizing oral drug absorptionManthena V Varma, Catherine M Ambler, Mohammad Ullah, et al.
Frontiers in Microbiology|April 20, 2016
Proteogenomic Analysis of Mycobacterium smegmatis Using High Resolution Mass SpectrometryMatthys G Potgieter, Kehilwe C Nakedi, Jon M Ambler, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 26, 2014
In vitro-in vivo evaluation of lipid based formulations of the CETP inhibitors CP-529,414 (torcetrapib) and CP-532,623Claire L McEvoy, Natalie L Trevaskis, Glenn A Edwards, et al.
Cancer Epidemiology|September 4, 2018
EPHA2 sequence variants are associated with susceptibility to Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma prevalence in HIV-infected patientsMelissa J Blumenthal, Charlotte Schutz, Graeme Meintjes, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Neurology|March 1, 1980
Adult celiac disease presenting as cerebellar syndromeP F Finelli, W J McEntee, M Ambler, et al.
Neurology|December 1, 1984
Cerebro-ocular dysgenesis (Walker-Warburg syndrome): neuropathologic and etiologic analysisR S Williams, C N Swisher, M Jennings, et al.
Archives of Neurology|March 1, 1978
Dominant spinopontine atrophy. Report of two additional members of family WS Pogacar, M Ambler, W J Conklin, et al.
Current Pharmaceutical Design|October 2, 2014
Strategies for skeletal muscle targeting in drug discoveryDavid C Ebner, Peter Bialek, Ayman F El-Kattan, et al.
Current Topics in Medicinal Chemistry|April 13, 2013
Intestinal targeting of drugs: rational design approaches and challengesKevin J Filipski, Manthena V Varma, Ayman F El-Kattan, et al.
Molecular Pharmaceutics|October 28, 2017
Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623Claire L McEvoy, Natalie L Trevaskis, Orlagh M Feeney, et al.
Current Drug Metabolism|December 30, 2010
Targeting intestinal transporters for optimizing oral drug absorptionManthena V Varma, Catherine M Ambler, Mohammad Ullah, et al.
Frontiers in Microbiology|April 20, 2016
Proteogenomic Analysis of Mycobacterium smegmatis Using High Resolution Mass SpectrometryMatthys G Potgieter, Kehilwe C Nakedi, Jon M Ambler, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 26, 2014
In vitro-in vivo evaluation of lipid based formulations of the CETP inhibitors CP-529,414 (torcetrapib) and CP-532,623Claire L McEvoy, Natalie L Trevaskis, Glenn A Edwards, et al.
Cancer Epidemiology|September 4, 2018
EPHA2 sequence variants are associated with susceptibility to Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma prevalence in HIV-infected patientsMelissa J Blumenthal, Charlotte Schutz, Graeme Meintjes, et al.
Pageof 3